维立志博涨超5% 近日奥帕替苏米单抗关键注册临床研究完成全部受试者入组

智通财经
Aug 18

维立志博(09887)涨超5%,截至发稿,涨4.54%,报72.5港元,成交额8642.91万港元。消息面上,据维立志博官微消息,8月14日,公司宣布,奥帕替苏米单抗(抗PD-L1/4-1BB双特异性抗体LBL-024)单臂关键注册临床研究已完成全部受试者入组(CTR20213023)。据介绍,奥帕替苏米单抗(LBL-024)是一种PD-L1与4-1BB双靶向双特异性抗体,为全球首款已处于单臂...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10